{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates the role of α-synuclein variants in neurodegeneration, likely related to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism involves protein aggregation and toxicity, relevant to the functional assays."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays are standard for assessing pathogenic effects.",
          "judgment": "Yes",
          "reasoning": "Cell viability relates directly to neurodegeneration.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Three replicates and statistical tests (one-way ANOVA) were used.",
          "judgment": "Yes",
          "reasoning": "Controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "WT and A30P variants serve as controls for each other.",
          "judgment": "Yes",
          "reasoning": "Variant controls are inferred from the experiment design.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical significance with p-values indicated.",
          "judgment": "No",
          "reasoning": "No direct OddsPath calculation mentioned.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "At least two variants used as controls.",
          "judgment": "Yes",
          "reasoning": "Total control variants are less than 10.",
          "next_step_or_outcome": "Evidence strength is supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant shows pathogenic effects based on cell viability assays with sufficient controls and replicates, leading to PS3_supporting strength."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "",
          "alt": "",
          "position": "0"
        },
        "variant_string_id": "SNCA WT"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study investigates the role of α-synuclein variants in neurodegeneration, likely related to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism involves protein aggregation and toxicity, relevant to the functional assays."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays are standard for assessing pathogenic effects.",
          "judgment": "Yes",
          "reasoning": "Cell viability relates directly to neurodegeneration.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Three replicates and statistical tests (one-way ANOVA) were used.",
          "judgment": "Yes",
          "reasoning": "Controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "WT and A30P variants serve as controls for each other.",
          "judgment": "Yes",
          "reasoning": "Variant controls are inferred from the experiment design.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical significance with p-values indicated.",
          "judgment": "No",
          "reasoning": "No direct OddsPath calculation mentioned.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "At least two variants used as controls.",
          "judgment": "Yes",
          "reasoning": "Total control variants are less than 10.",
          "next_step_or_outcome": "Evidence strength is supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The wild-type α-synuclein shows pathogenic effects in cell viability assays with sufficient controls and replicates, leading to PS3_supporting strength."
    }
  ]
}